Find the right fit for you - faster
Get tailored insights about working at SkyePharma in one quick step.
SkyePharma Snapshot
There's good karma for aging pharmaceuticals at SkyePharma. The company uses its controlled-release drug delivery technologies for inhaled, oral, and topical drugs to produce more effective versions of already proven therapies. It makes money from partnerships with other pharmaceutical companies, such as GlaxoSmithKline and Shionogi Pharma (formerly Sciele Pharma), who seek out SkyePharma's drug delivery expertise. The firm also develops some compounds on its own and then licenses them to others for marketing. Its lead proprietary candidate is Flutiform, an inhaled treatment for asthma and chronic obstructive pulmonary disease (COPD).
